Home › Funds › Davis Balanced Fund
Fund family: DAVIS SERIES INC · Filed by DAVIS SERIES INC (CIK 203002) · SEC series S000003446
Share classes and tickers: DCSCX (C000009545), DCSYX (C000009546), RPFCX (C000009543)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 484 with, 43 against, 0 abstentions (not counted as with management); 4 items carried no recommendation. Shareholder proposals: 7 FOR, 40 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other DAVIS SERIES INC funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
The same votes as “with management” above, by the sector of the company voted on. 72.1% of this fund’s 527 such votes could be given a sector; the other 147 (27.9%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 153 | 14 | 9.2% |
| Health Care | 77 | 3 | 3.9% |
| Technology | 70 | 16 | 22.9% |
| Industrials | 30 | 1 | 3.3% |
| Consumer Discretionary | 17 | 4 | 23.5% |
| Consumer Staples | 17 | 1 | 5.9% |
| Energy | 16 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 329 | 0 |
| Corporate Governance | 58 | 17 |
| Audit-related | 34 | 0 |
| Capital Structure | 30 | 0 |
| Compensation | 26 | 2 |
| Say-on-Pay | 25 | 0 |
| Environment or Climate | 10 | 10 |
| Other Social Issues | 9 | 9 |
| Extraordinary Transactions | 6 | 0 |
| Human Rights or Human Capital/workforce | 4 | 4 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Viatris Inc. | December 5, 2025 | $23M | 15 | 0 |
| Viatris Inc. | May 15, 2026 | $22M | 15 | 0 |
| Berkshire Hathaway Inc. | May 2, 2026 | $21M | 16 | 1 |
| Quest Diagnostics Incorporated | May 20, 2026 | $19M | 14 | 1 |
| Applied Materials, Inc. | March 12, 2026 | $17M | 12 | 0 |
| CVS Health Corporation | May 14, 2026 | $16M | 17 | 1 |
| Capital One Financial Corporation | May 8, 2026 | $15M | 16 | 1 |
| Amazon.com, Inc. | May 20, 2026 | $11M | 17 | 4 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 2, 2026 | Berkshire Hathaway Inc. | Shareholder proposal requesting that the Company issue a report disclosing the Board's oversight framework for workforce and human-capital management across its operating subsidiaries. Shareholder proposal | Against | For |
| May 20, 2026 | Quest Diagnostics Incorporated | Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | Against | For |
| May 8, 2026 | Capital One Financial Corporation | Stockholder proposal to require a shareholder vote on golden parachute arrangements. Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| April 16, 2026 | Texas Instruments Incorporated | Stockholder proposal to permit stockholders to act by written consent. Shareholder proposal | Against | For |
| April 22, 2026 | The Cigna Group | Shareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 20, 2026 | Markel Group Inc. | Shareholder proposal for a report on the Company's strategies and action plans to mitigate material environmental risks. Shareholder proposal | Against | For |
| May 20, 2026 | Markel Group Inc. | Shareholder proposal to give shareholders an ability to call for a special shareholder meeting. Shareholder proposal | Against | For |
532 ballot items at 33 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Davis Balanced Fund (DCSCX) voted at 33 shareholder meetings of 32 companies, on 532 ballot items in all. Where management made a recommendation, the fund followed it on 91.8% of the items and voted against it 43 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 47 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.